Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1∗01.

Ferlito C, Biselli R, Mariotti S, von Hunolstein C, Teloni R, Ralli L, Pinto A, Pisani G, Tirelli V, Biondo MI, Salerno G, Andreasi Bassi L, Lulli P, Autore A, Scagliusi A, Tomao E, Germano V, Picchianti Diamanti A, Caporuscio S, Milanetti F, Salemi S, Nisini R, D'Amelio R.

Vaccine. 2018 Oct 29;36(45):6718-6725. doi: 10.1016/j.vaccine.2018.09.041. Epub 2018 Sep 27.

PMID:
30269918
2.

Anti-polysaccharide and anti-diphtheria protective antibodies after 13-valent pneumococcal conjugate vaccination in rheumatoid arthritis patients under immunosuppressive therapy.

Caporuscio S, Ieraci R, Valesini G, Teloni R, Mariotti S, Spinelli FR, Ferlito C, Salemi S, Picchianti Diamanti A, Meneguzzi G, Markovic M, Sgrulletti M, von Hunolstein C, Ralli L, Pinto A, Salerno G, Canzoni M, Sorgi ML, Laganà B, Di Rosa R, Nisini R, D'Amelio R.

Clin Immunol. 2018 Oct;195:18-27. doi: 10.1016/j.clim.2018.07.010. Epub 2018 Jul 21.

PMID:
30036638
3.

Collaborative study on saccharide quantification of the Haemophilus influenzae type b component in liquid vaccine presentations.

Rosskopf U, Daas A, Terao E, von Hunolstein C.

Pharmeur Bio Sci Notes. 2017;2017:44-68.

PMID:
29017702
4.

Adherence and invasive properties of Corynebacterium diphtheriae strains correlates with the predicted membrane-associated and secreted proteome.

Sangal V, Blom J, Sutcliffe IC, von Hunolstein C, Burkovski A, Hoskisson PA.

BMC Genomics. 2015 Oct 9;16:765. doi: 10.1186/s12864-015-1980-8.

5.

Tetanus in Italy 2001-2010: a continuing threat in older adults.

Filia A, Bella A, von Hunolstein C, Pinto A, Alfarone G, Declich S, Rota MC.

Vaccine. 2014 Feb 3;32(6):639-44. doi: 10.1016/j.vaccine.2013.12.012. Epub 2013 Dec 25.

PMID:
24370712
6.

Calibration and commutability assessment of the 1st International Standard for Diphtheria Antitoxin Human.

Stickings P, Rigsby P, Coombes L, von Hunolstein C, Ralli L, Pinto A, Sesardic D.

Biologicals. 2013 Nov;41(6):384-92. doi: 10.1016/j.biologicals.2013.08.001. Epub 2013 Sep 5.

PMID:
24011675
7.

Identification and molecular discrimination of toxigenic and nontoxigenic diphtheria Corynebacterium strains by combined real-time polymerase chain reaction assays.

Mancini F, Monaco M, Pataracchia M, von Hunolstein C, Pantosti A, Ciervo A.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):111-20. doi: 10.1016/j.diagmicrobio.2012.02.022. Epub 2012 Apr 10.

PMID:
22494559
8.

Comparative seroepidemiology of diphtheria in six European countries and Israel.

di Giovine P, Kafatos G, Nardone A, Andrews N, Ölander RM, Alfarone G, Broughton K, Cohen D, Kriz B, Mikova I, O'Flanagan D, Schneider F, Selga I, Valinsky L, Velicko I, Karacs I, Pebody R, von Hunolstein C.

Epidemiol Infect. 2013 Jan;141(1):132-42. doi: 10.1017/S0950268812000210. Epub 2012 Feb 24.

PMID:
22361223
9.

Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid.

van Gageldonk PG, von Hunolstein C, van der Klis FR, Berbers GA.

Clin Vaccine Immunol. 2011 Jul;18(7):1183-6. doi: 10.1128/CVI.05081-11. Epub 2011 May 25.

10.

External quality assessment for the determination of diphtheria antitoxin in human serum.

Di Giovine P, Pinto A, Olander RM, Sesardic D, Stickings P, Berbers G, Neal S, Efstratiou A, Paberza R, Dauksiene S, Bujko M, Detcheva A, Joks U, Levent B, von Hunolstein C.

Clin Vaccine Immunol. 2010 Aug;17(8):1282-90. doi: 10.1128/CVI.00096-10. Epub 2010 Jul 7.

11.

Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007-2008: a multicentre European study.

Wagner KS, White JM, Neal S, Crowcroft NS, Kuprevičiene N, Paberza R, Lucenko I, Jõks U, Akbaş E, Alexandrou-Athanassoulis H, Detcheva A, Vuopio J, von Hunolstein C, Murphy PG, Andrews N; Members of the Diphtheria Surveillance Network, Efstratiou A.

Clin Microbiol Infect. 2011 Apr;17(4):519-25. doi: 10.1111/j.1469-0691.2010.03269.x.

12.

Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.

von Hunolstein C, Gomez Miguel MJ, Pezzella C, Scopetti F, Behr-Gross ME, Halder M, Hoffmann S, Levels L, van der Gun J, Hendriksen C.

Pharmeuropa Bio. 2008 Dec;2008(1):7-18.

PMID:
19220977
13.

Isolation of Corynebacterium tuscaniae sp. nov. from blood cultures of a patient with endocarditis.

Riegel P, Creti R, Mattei R, Nieri A, von Hunolstein C.

J Clin Microbiol. 2006 Feb;44(2):307-12.

14.

Experimental model of infection with non-toxigenic strains of Corynebacterium diphtheriae and development of septic arthritis.

Puliti M, von Hunolstein C, Marangi M, Bistoni F, Tissi L.

J Med Microbiol. 2006 Feb;55(Pt 2):229-35.

PMID:
16434717
15.

Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation.

Creti R, Gherardi G, Imperi M, von Hunolstein C, Baldassarri L, Pataracchia M, Alfarone G, Cardona F, Dicuonzo G, Orefici G.

J Med Microbiol. 2005 Oct;54(Pt 10):913-7.

PMID:
16157543
16.

Internalization of non-toxigenic Corynebacterium diphtheriae by cultured human respiratory epithelial cells.

Bertuccini L, Baldassarri L, von Hunolstein C.

Microb Pathog. 2004 Sep;37(3):111-8.

PMID:
15351033
17.

Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice.

Puliti M, von Hunolstein C, Bistoni F, Orefici G, Tissi L.

Infect Immun. 2004 Aug;72(8):4891-4.

18.

Antibody classes & subclasses induced by mucosal immunization of mice with Streptococcus pyogenes M6 protein & oligodeoxynucleotides containing CpG motifs.

Teloni R, von Hunolstein C, Mariotti S, Donati S, Orefici G, Nisini R.

Indian J Med Res. 2004 May;119 Suppl:126-30.

PMID:
15232177
19.

Role of interleukin-18 in experimental group B streptococcal arthritis.

Tissi L, McRae B, Ghayur T, von Hunolstein C, Orefici G, Bistoni F, Puliti M.

Arthritis Rheum. 2004 Jun;50(6):2005-13.

20.

Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes.

Creti R, Fabretti F, Orefici G, von Hunolstein C.

J Clin Microbiol. 2004 Mar;42(3):1326-9.

21.

Simple and rapid technique for monitoring the quality of meningococcal polysaccharides by high performance size-exclusion chromatography.

von Hunolstein C, Parisi L, Bottaro D.

J Biochem Biophys Methods. 2003 Jun 30;56(1-3):291-6.

PMID:
12834984
22.

Surveillance of systemic invasive disease caused by group A Streptococcus in Italy 1994-1996.

Suligoi B, Von Hunolstein C, Orefici G, Scopetti F, Pataracchia M, Greco D.

Euro Surveill. 1998 Feb;3(2):11-14.

PMID:
12631781
23.

Molecular epidemiology and characteristics of Corynebacterium diphtheriae and Corynebacterium ulcerans strains isolated in Italy during the 1990s.

von Hunolstein C, Alfarone G, Scopetti F, Pataracchia M, La Valle R, Franchi F, Pacciani L, Manera A, Giammanco A, Farinelli S, Engler K, De Zoysa A, Efstratiou A.

J Med Microbiol. 2003 Feb;52(Pt 2):181-8.

PMID:
12543926
24.

Role of macrophages in experimental group B streptococcal arthritis.

Puliti M, von Hunolstein C, Bistoni F, Castronari R, Orefici G, Tissi L.

Cell Microbiol. 2002 Oct;4(10):691-700.

PMID:
12366405
25.

Penicillin tolerance amongst non-toxigenic Corynebacterium diphtheriae isolated from cases of pharyngitis.

von Hunolstein C, Scopetti F, Efstratiou A, Engler K.

J Antimicrob Chemother. 2002 Jul;50(1):125-8.

PMID:
12096018
26.

Regulatory role of interleukin-10 in experimental group B streptococcal arthritis.

Puliti M, Von Hunolstein C, Verwaerde C, Bistoni F, Orefici G, Tissi L.

Infect Immun. 2002 Jun;70(6):2862-8.

27.
28.

The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production.

Puliti M, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L.

Arthritis Rheum. 2002 Mar;46(3):806-17.

29.

Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age.

Ciofi degli Atti ML, Salmaso S, Cotter B, Gallo G, Alfarone G, Pinto A, Bella A, von Hunolstein C.

Vaccine. 2001 Oct 12;20(1-2):74-9. Erratum in: Vaccine 2001 Dec 12;20(5-6):989.

PMID:
11567748
30.
31.

Invasive Streptococcus pyogenes infection in a surgeon after an occupational exposure.

Corti G, Bartoloni A, von Hunolstein C, Scopetti F, Buonomini MI, Galligani R, Paradisi F.

Clin Microbiol Infect. 2000 Mar;6(3):170-1. No abstract available.

32.

Influence of interferon-gamma administration on the severity of experimental group B streptococcal arthritis.

Puliti M, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L.

Arthritis Rheum. 2000 Dec;43(12):2678-86.

33.

Severity of group B streptococcal arthritis in selected strains of laboratory mice.

Puliti M, Bistoni F, von Hunolstein C, Orefici G, Tissi L.

Infect Immun. 2001 Jan;69(1):551-5.

34.

The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.

Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, Hallander HO, Olander R, Maple PA, Melker HE, Olin P, Fievret-Groyne F, Rota C, Salmaso S, Tischer A, von-Hunolstein C, Miller E.

Epidemiol Infect. 2000 Aug;125(1):113-25. Erratum in: Epidemiol Infect 2001 Apr;126(2):331.

35.

Severity of group B streptococcal arthritis is correlated with beta-hemolysin expression.

Puliti M, Nizet V, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L.

J Infect Dis. 2000 Sep;182(3):824-32. Epub 2000 Aug 17.

PMID:
10950777
36.

Diphtheria antibody levels in the Italian Population.

von Hunolstein C, Rota MC, Alfarone G, Ricci ML, Salmaso S; Italian Serology Working Group.

Eur J Clin Microbiol Infect Dis. 2000 Jun;19(6):433-7.

PMID:
10947218
37.

European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays.

von Hunolstein C, Aggerbeck H, Andrews N, Berbers G, Fievet-Groyne F, Maple PA, Olander RM, Raux M, Tischer A.

Vaccine. 2000 Aug 1;18(28):3287-96.

PMID:
10869774
38.
39.

Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Cuzzola M, Mancuso G, Beninati C, Biondo C, von Hunolstein C, Orefici G, Espevik T, Flo TH, Teti G.

Infect Immun. 2000 Feb;68(2):994-8.

40.

Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.

von Hunolstein C, Parisi L, Tissi L, Recchia S, Alfarone G, Nicolini L, Volpe C, Wagner B, Motlovà J, Orefici G.

J Med Microbiol. 1999 Nov;48(11):983-90.

PMID:
10535641
41.

Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis.

Tissi L, Puliti M, Barluzzi R, Orefici G, von Hunolstein C, Bistoni F.

Infect Immun. 1999 Sep;67(9):4545-50.

42.
44.

Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.

Tissi L, von Hunolstein C, Bistoni F, Marangi M, Parisi L, Orefici G.

J Med Microbiol. 1998 Aug;47(8):717-23.

PMID:
9877193
45.

Group B streptococci persist inside macrophages.

Cornacchione P, Scaringi L, Fettucciari K, Rosati E, Sabatini R, Orefici G, von Hunolstein C, Modesti A, Modica A, Minelli F, Marconi P.

Immunology. 1998 Jan;93(1):86-95.

46.

Soluble antigens from group B streptococci induce cytokine production in human blood cultures.

von Hunolstein C, Totolian A, Alfarone G, Mancuso G, Cusumano V, Teti G, Orefici G.

Infect Immun. 1997 Oct;65(10):4017-21.

47.

Carriage of group B Streptococcus in pregnant women and newborns: a 2-year study at Perugia General Hospital.

Sensini A, Tissi L, Verducci N, Orofino M, von Hunolstein C, Brunelli B, Malà GL, Perocchi F, Brunelli R, Lauro V, Ferrarese R, Gilardi G.

Clin Microbiol Infect. 1997 Jun;3(3):324-328.

48.

Cytokine production in an ex vivo whole blood model following induction by group B streptococcal polysaccharides and lipoteichoic acid.

von Hunolstein C, Totolian A, Alfarone G, Teti G, Orefici G.

Adv Exp Med Biol. 1997;418:893-6. No abstract available.

PMID:
9331793
49.

Group B streptococci. Role of capsular polysaccharide on virulence and induction of septic arthritis.

Tissi L, von Hunolstein C, Parisi L, Bistoni F, Orefici G.

Adv Exp Med Biol. 1997;418:817-8. No abstract available.

PMID:
9331777
50.

Clinical and microbiological characteristics of severe group A streptococcal infections in Italy.

von Hunolstein C, Suligoi B, Pataracchia M, Scopetti F, Recchia S, Greco D, Orefici G.

Adv Exp Med Biol. 1997;418:79-81. No abstract available.

PMID:
9331604

Supplemental Content

Loading ...
Support Center